BindingDB logo
myBDB logout

BDBM241529 US9409908, 161

SMILES: COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc-2c3)c1

InChI Key: InChIKey=YPAISRDCVKHFMI-CLYVBNDRSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 241529   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Coagulation factor IX and X


(Homo sapiens (human))
BDBM241529
PNG
(US9409908, 161)
Show SMILES COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc-2c3)c1
Show InChI InChI=1S/C32H30BrClFN3O4/c1-18-5-3-8-27(38-14-13-21(16-28(38)39)29-24(33)11-12-25(34)30(29)35)20-7-4-6-19(15-20)23-10-9-22(36-32(41)42-2)17-26(23)37-31(18)40/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,41)(H,37,40)/t18-,27+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
0.590n/an/an/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 145 mM NaCl, 5 mM KCl, and 0.1% PEG 8000 (polyethylene glycol; JT Bake...


US Patent US9409908 (2016)


BindingDB Entry DOI: 10.7270/Q27943K8
More data for this
Ligand-Target Pair
Plasma kallikrein


(Homo sapiens (Human))
BDBM241529
PNG
(US9409908, 161)
Show SMILES COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc-2c3)c1
Show InChI InChI=1S/C32H30BrClFN3O4/c1-18-5-3-8-27(38-14-13-21(16-28(38)39)29-24(33)11-12-25(34)30(29)35)20-7-4-6-19(15-20)23-10-9-22(36-32(41)42-2)17-26(23)37-31(18)40/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,41)(H,37,40)/t18-,27+/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
21.6 -10.9n/an/an/an/an/an/a37



Bristol-Myers Squibb Company

US Patent


Assay Description
Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. De...


US Patent US9409908 (2016)


BindingDB Entry DOI: 10.7270/Q27943K8
More data for this
Ligand-Target Pair